Anil Narayana Swamy Patel

Anil Narayana Swamy Patel

Active Director Director DIN 07153120
DIN 07153120 First appointment Apr 2015 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Anil Narayana Swamy Patel

Data last updated:

Anil Narayana Swamy Patel is a Director at Entox Biogene Private Limited (since 2015). The company operates in Business Services.

DIN 07153120
Primary Designation Director
Industry Business Services
First Appointment 24 Apr 2015
Oldest Company Age 11 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Entox Biogene Private Limited U74900KA2015PTC079935
Director24 Apr 20152015Active

Board colleagues of Anil Narayana Swamy Patel

NameDINCompanyDesignation
Rashmi Ramachandraswamy07153125Entox Biogene Private LimitedDirector

Directorship timeline

Open interactive timeline →
Entox Biogene Private Limited
Premium access

Shareholding and investment profile for Anil Narayana Swamy Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Narayana Swamy Patel

Anil Narayana Swamy Patel currently holds 1 directorship: Entox Biogene Private Limited (Director, since 24 Apr 2015).

Anil Narayana Swamy Patel was first appointed on 24 Apr 2015 as Director at Entox Biogene Private Limited.

The current boards of Anil Narayana Swamy Patel's companies include Rashmi Ramachandraswamy (Entox Biogene Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available